Walter Evangelista

Summary

Country: Italy

Publications

  1. ncbi request reprint Sentinel lymph node mapping in colorectal cancer: a feasibility study
    Walter Evangelista
    Department of Oncology, Medical Oncology Service, Azienda Ospedaliera San Giovanni Battista, Turin, Italy
    Tumori 88:37-40. 2002
  2. doi request reprint Efficacy and skin toxicity management with cetuximab in metastatic colorectal cancer: outcomes from an oncologic/dermatologic cooperation
    Patrizia Racca
    Centro Universitario di Ricerca Oncologica, Oncologia Medica I, ASO San Giovanni Battista Ospedale Molinette, Torino, Italy
    Clin Colorectal Cancer 7:48-54. 2008
  3. ncbi request reprint Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nor
    Alfredo Falcone
    U O Oncologia Medica, Istituto Toscano Tumori, Livorno, Italy
    J Clin Oncol 25:1670-6. 2007

Collaborators

Detail Information

Publications3

  1. ncbi request reprint Sentinel lymph node mapping in colorectal cancer: a feasibility study
    Walter Evangelista
    Department of Oncology, Medical Oncology Service, Azienda Ospedaliera San Giovanni Battista, Turin, Italy
    Tumori 88:37-40. 2002
    ..The aim of this study was to evaluate the feasibility of SLN mapping in colorectal cancer and to assess its impact on pathological staging and treatment...
  2. doi request reprint Efficacy and skin toxicity management with cetuximab in metastatic colorectal cancer: outcomes from an oncologic/dermatologic cooperation
    Patrizia Racca
    Centro Universitario di Ricerca Oncologica, Oncologia Medica I, ASO San Giovanni Battista Ospedale Molinette, Torino, Italy
    Clin Colorectal Cancer 7:48-54. 2008
    ..The aim of this study was to investigate the efficacy of the combination of irinotecan/cetuximab and to plan related skin toxicity management with an oncologic/dermatologic team...
  3. ncbi request reprint Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nor
    Alfredo Falcone
    U O Oncologia Medica, Istituto Toscano Tumori, Livorno, Italy
    J Clin Oncol 25:1670-6. 2007
    ....